Wenming Liu Selected Research

Lab-On-A-Chip Devices

10/2021	Parallel and large-scale antitumor investigation using stable chemical gradient and heterotypic three-dimensional tumor coculture in a multi-layered microfluidic device.
10/2020	An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation.
11/2015	Deformability and size-based cancer cell separation using an integrated microfluidic device.
2/2015	Controllable organization and high throughput production of recoverable 3D tumors using pneumatic microfluidics.
2/2015	High throughput and multiplex localization of proteins and cells for in situ micropatterning using pneumatic microfluidics.
2/2013	Construction of oxygen and chemical concentration gradients in a single microfluidic device for studying tumor cell-drug interactions in a dynamic hypoxia microenvironment.
1/2013	Investigation of hypoxia-induced myocardial injury dynamics in a tissue interface mimicking microfluidic device.
8/2012	Spatiotemporally controlled and multifactor involved assay of neuronal compartment regeneration after chemical injury in an integrated microfluidics.
5/2012	An enzymatic immunoassay microfluidics integrated with membrane valves for microsphere retention and reagent mixing.
9/2010	Lectin-aided separation of circulating tumor cells and assay of their response to an anticancer drug in an integrated microfluidic device.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenming Liu Research Topics

Disease

28	Neoplasms (Cancer) 10/2021 - 12/2009
6	Stomach Neoplasms (Stomach Cancer) 01/2021 - 09/2015
5	Myocardial Infarction 01/2013 - 06/2009
4	Infections 01/2020 - 02/2016
4	Glioblastoma (Glioblastoma Multiforme) 11/2016 - 11/2011
3	Carcinogenesis 10/2021 - 01/2017
3	Carcinoma (Carcinomatosis) 01/2021 - 12/2009
3	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2015
3	Hypoxia (Hypoxemia) 09/2014 - 01/2013
3	Glioma (Gliomas) 01/2011 - 12/2009
2	Sepsis (Septicemia) 09/2022 - 12/2017
2	Ischemic Stroke 01/2022 - 10/2021
2	Reperfusion Injury 01/2022 - 10/2021
2	Pneumonia (Pneumonitis) 01/2022 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2018 - 11/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 03/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2022
1	Lung Injury 09/2022
1	Acute Lung Injury 09/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2021
1	Brain Ischemia (Cerebral Ischemia) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Viremia 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Foot-and-Mouth Disease 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Coinfection 04/2019
1	Disease Progression 04/2019
1	Shock 04/2019
1	Heat Stroke (Heatstroke) 04/2019
1	Burns 01/2019
1	Overweight 01/2019

Drug/Important Bio-Agent (IBA)

13	Pharmaceutical PreparationsIBA 10/2021 - 12/2009
8	Proteins (Proteins, Gene)FDA Link 09/2022 - 08/2009
5	Biological ProductsIBA 10/2019 - 02/2015
5	Indicators and Reagents (Reagents)IBA 06/2019 - 09/2014
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2009
4	Fatty Acid Binding Protein 3IBA 05/2012 - 06/2009
4	Fatty Acid-Binding ProteinsIBA 05/2012 - 06/2009
4	MyoglobinIBA 05/2012 - 06/2009
3	Oxygen (Dioxygen)IBA 10/2021 - 02/2013
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2017
3	Antineoplastic Agents (Antineoplastics)IBA 11/2019 - 02/2013
2	GlycogenIBA 01/2022 - 10/2021
2	LipopolysaccharidesIBA 01/2022 - 08/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2016
2	Long Noncoding RNAIBA 01/2020 - 01/2017
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 09/2015
2	ChromatinIBA 01/2020 - 11/2011
2	EpitopesIBA 06/2019 - 02/2016
2	Messenger RNA (mRNA)IBA 08/2018 - 01/2017
2	cadherin 5IBA 01/2017 - 05/2014
2	Lysine (L-Lysine)FDA Link 01/2013 - 05/2012
1	EndotoxinsIBA 09/2022
1	Heme Oxygenase-1IBA 09/2022
1	NAD (NADH)IBA 09/2022
1	CollagenIBA 01/2022
1	tricinIBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	salvianolic acid BIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	ethyl acetateIBA 01/2021
1	gracillinIBA 01/2021
1	KinesinsIBA 01/2020
1	VaccinesIBA 01/2020
1	Attenuated VaccinesIBA 01/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2020
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Prealbumin (Transthyretin)IBA 04/2019
1	fibrin fragment D (D-dimer)IBA 04/2019
1	lycorineIBA 01/2019
1	isoquinolineIBA 01/2019
1	AlkaloidsIBA 01/2019
1	CateninsIBA 01/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2019

Therapy/Procedure

12	Therapeutics 09/2022 - 05/2012
10	Lab-On-A-Chip Devices 10/2021 - 09/2010
7	Drug Therapy (Chemotherapy) 10/2021 - 10/2015
4	Microspheres (Microsphere) 01/2020 - 06/2009
2	Nutrition Therapy (Medical Nutrition Therapy) 01/2022 - 01/2019
2	Transplantation 12/2018 - 09/2014
1	Cardiopulmonary Resuscitation (CPR) 01/2020
1	Neoadjuvant Therapy 06/2019
1	Intermittent Positive-Pressure Ventilation 04/2019
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 04/2019
1	Nutritional Support (Artificial Feeding) 01/2019